On 2 April, US President Donald Trump announced the implementation of reciprocal tariffs on about 60 countries, escalating global trade tensions. On 9 April,...
Despite brief relief, the US-China trade war escalated as Trump hiked tariffs on Chinese goods to 125% after China raised its tariffs on US goods to 84% from April 10.
India’s pharma industry relies heavily on US market, with $8.07 bn worth of exports in FY 2023-2024. Pharmaceuticals are India’s third largest goods exported to US in dollar terms.
India has had a unique approach to Trump 2.0. It has been at once the most enthusiastic, conciliatory and the biggest votary of the ‘method behind the madness’ theory.
A long list of reforms has begun doing the rounds among policy experts, industry bodies, and think tanks. The argument is to help Indian economy weather the storm unleashed by Trump's tariff regime.
Institute of Chinese Studies held discussion on 'Two Sessions' meeting of China’s domestic political bodies, where Beijing outlined its domestic framework for future economic growth.
While global corporations setting up GCCs in India continue to express confidence in availability of skilled AI engineers, the panel argued that India’s real challenge lies elsewhere.
The Government of India has requested to buy up to 216 M982A1 Excalibur tactical projectiles too. Excalibur artillery munition was used in Op Sindoor against Pakistan.
Without a Congress revival, there can be no challenge to the BJP pan-nationally. Modi’s party is growing, and almost entirely at the cost of the Congress.
COMMENTS